Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 76 to 90 of 214 results for arthritis

  1. NICE considered that there is an important need for head-to-head comparisons between biological treatments for psoriatic arthritis, particularly in people for whom treatment with tumour necrosis factor (TNF) alpha inhibitors has been unsuccessful.

    for head-to-head comparisons between biological treatments for psoriatic arthritis, particularly in people for whom treatment with...

    Research recommendation
    Published
    5 October 2015

  2. Digital technologies for managing mild to moderate symptoms of hip or knee osteoarthritis: early-value assessment

    In development Reference number: GID-HTE10057 Expected publication date:  22 January 2026

    Health technology evaluations
    In development

  3. secondary research is recommended to understand the clinical validity of enzyme-linked immunosorbent assay (ELISA) tests, that is the correlation between ELISA test results and health outcomes or states, such as remission, response, low or high disease activity or flares in rheumatoid arthritis

    remission, response, low or high disease activity or flares in rheumatoid arthritis Any explanatory notes(if applicable) Source guidance...

    Research recommendation
    Published
    25 October 2019

  4. Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn's disease and ulcerative colitis (ES35)

    Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn’s disease and ulcerative colitis

    Evidence summary
    Published
    24 February 2021

  5. Multiple long-term conditions: medication review (IND207)

    This indicator covers the percentage of patients with moderate or severe frailty and/or multimorbidity who have received a medication review in the last 12 months which is structured, has considered the use of a recognised tool and taken place as a shared discussion. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM186

    General practice indicators suitable for use in QOF
    Published
    31 July 2019

  6. Apremilast for treating juvenile psoriatic arthritis in people 5 to 17 years [TSID12089]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  7. Mini-incision surgery for total knee replacement (IPG345)

    Evidence-based recommendations on mini-incision surgery for total knee replacement. This involves using specially designed instruments to replace the knee using a smaller incision.

    Interventional procedures guidance
    Published
    26 May 2010
    View recommendations

    Sections for IPG345

  8. Total wrist replacement (IPG271)

    Evidence-based recommendations on total wrist replacement. This involves creating an artificial wrist joint consisting of metal implants attached to the end of the arm and to the hand, separated by a spacer to allow movement.

    Interventional procedures guidance
    Published
    27 August 2008
    View recommendations

    Sections for IPG271

  9. Osteoarthritis in over 16s: diagnosis and management (NG226)

    This guideline covers the diagnosis, assessment and non-surgical management of osteoarthritis. It aims to improve management of osteoarthritis and the quality of life for people with osteoarthritis.

    NICE guideline
    Published
    19 October 2022
    View recommendations

    Sections for NG226

  10. Evidence on the safety and efficacy of lateral elbow resurfacing for arthritis is limited in quantity and quality. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE interventional procedures guidance page. Further research, which could include case series with long-term follow up, should report range of motion, patient-reported outcomes and complications.

    Evidence on the safety and efficacy of lateral elbow resurfacing for arthritis is limited in quantity and quality. Therefore, this...

    Research recommendation
    Published
    30 September 2021

  11. Past appeals and decisions

    Past technology appraisal appeals and decisions

  12. Refractory extrapulmonary sarcoidosis: infliximab (ES4)

    Summary of the evidence on infliximab for treating refractory extrapulmonary sarcoidosis to inform local NHS planning and decision-making

    Evidence summary
    Published
    17 January 2017

  13. Older people with social care needs and multiple long-term conditions (NG22)

    This guideline covers planning and delivering social care and support for older people who have multiple long-term conditions. It promotes an integrated and person-centred approach to delivering effective health and social care services.

    NICE guideline
    Published
    4 November 2015
    View recommendations

    Sections for NG22

  14. Assessment of disease severity and impact:- In children, young people and adults with psoriasis, can tools be developed and/or existing ones further refined and validated to: - assess disease severity and impact in both non-specialist and specialist healthcare settings, to facilitate assessment, appropriate referral, treatment planning and measurement of outcomes - measure burden and cumulative effect of disease activity, severity and impact for people with both psoriasis and psoriatic arthritis?

    activity, severity and impact for people with both psoriasis and psoriatic arthritis? Any explanatory notes(if applicable) Why this is...

    Research recommendation
    Published
    9 June 2015

  15. Avtozma (tocilizumab biosimilar) for treating moderate to severe rheumatoid arthritis in people aged 18 to 75 [TSID11848]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation